Alluvi NAD⁺ 1,000 mg is supplied specifically for R&D purposes, allowing researchers to conduct quantitative analysis and comparative testing with verified purity and batch traceability. No therapeutic or diagnostic use is implied or permitted.
A 40mg Tirzepatide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.
Get access to your Orders, Wishlist and Recommendations.
Signup
Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.
